On April 26, more than 6,000 people participated in the 7th Annual Tar Heel 10 Miler
UNC Lineberger selected to join A Survivor Action Partnership to improve the lives of prostate cancer survivors
UNC Lineberger has been selected to participate in A Survivor Action Partnership – United States of America (ASAP USA), a consortium of institutions that will collaborate to develop and study interventions to improve the lives of prostate cancer survivors in the United States. Sixteen institutions were selected following a peer reviewed application process. Ronald Chen, MD, MPH, assistant professor of radiation oncology is leading the UNC Lineberger ASAP USA team.
The Leukemia & Lymphoma Society's Man & Woman of the Year (MWOY) campaign is a national fundraising competition in which participants vie for the title of Man or Woman of the Year. They raise funds for blood cancer research in honor of local children who are blood cancer survivors. The titles are awarded to the men and women who raise the most funds during the campaign in their communities. The top local fundraisers in the country also win the national titles.
Five questions for Chuck Perou, PhD, a UNC geneticist on the hunt for better treatments for the most deadly form of breast cancer
Cell movement plays an important role in a host of biological functions from embryonic development to repairing wounded tissue. It also enables cancer cells to break free from their sites of origin and migrate throughout the body.
UNC Lineberger member Deborah K. Mayer, PhD, RN, AOCN, FAAN, was awarded $50,000 in funding through the UNC School of Medicine’s Institute for Healthcare Quality Improvement seed grant program for her proposal “Implementing Survivorship Care Plans.”
Andrew Tucker, PhD, used his graduate experience at UNC to help build a new kind of mammographic imaging machine now in use in a clinical trial at the North Carolina Cancer Hospital.
The John William Pope Foundation has made a $1.3 million gift to UNC Lineberger Comprehensive Cancer Center to fund cancer research and treatment.
UNC Lineberger member Gary Johnson, PhD, professor and chair of the UNC Department of Pharmacology, has been tapped to join Synodos, a team of scientists working together to defeat the rare genetic disorder neurofibromatosis type 2 (NF2). A first-of-its-kind NF research collaboration, Synodos has brought together centers of excellence from institutions across the country. Johnson will be just one of 12 academic researchers in the collaboration.
Please join Team Lineberger for the Bladder Cancer Advocacy Network (BCAN) annual walk to raise awareness about bladder cancer on May 3, 2014 in Hillsborough, NC.
The push and pull of physical force can cause profound changes in the behavior of a cell. Two studies from researchers working at the UNC Lineberger Comprehensive Cancer Center reveal how cells respond to mechanical manipulation.
UNC Lineberger to be involved in first research challenge using Project Data Sphere Initiative, a new data sharing platform launched by CEO Roundtable on Cancer
UNC Lineberger Comprehensive Cancer Center has contributed to the development of the first national “research challenge” involving the newly launched Project Data Sphere, LLC (PDS), an independent not-for-profit initiative of the CEO Roundtable on Cancer’s Life Sciences Consortium (LSC).
UNC Lineberger helped celebrate the opening of Marsico Hall today, the newest research building to house an impressive array of programs, including several affiliated with the cancer center.
Science Magazine interviewed UNC Lineberger members Charles Perou, PhD, and James Evans, MD, PhD, for a special feature on “The ‘Other’ Breast Cancer Genes.”
Researchers at the UNC Lineberger Comprehensive Cancer Center and the University of Texas Southwestern Medical Center will investigate the role of proteins linked both to human sexual reproduction and cancer tumor formation thanks to a grant from the U.S. Department of Defense (DoD).
Members of the UNC Lineberger Comprehensive Cancer Center will share their research and expertise at the 105th Annual Meeting of the American Association for Cancer Research (AACR) on April 5 to 9 in San Diego, Calif. The event will host more than 18,000 researchers, patient advocates and other professionals in the cancer field to share the year’s foremost basic science, translational and clinical advances.
Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.
The University of North Carolina at Chapel Hill will dedicate Marsico Hall (formerly called the IRB building or the BRIC building) at 3:30 p.m. Thursday, March 27. The event will also begin streaming live online once the ceremony has begun.
RNA encodes the proteins that play a key role in cellular reproduction, but the manner in which cells regulate its removal once these proteins are synthesized remains a mystery. One piece of this mystery has been solved as researchers at the University of North Carolina at Chapel Hill who have identified the steps by which a cell removes RNA from the cytoplasm.
The Metastatic Breast Cancer Network (MBCN) is pleased to announce it will hold its 8th Annual National Conference September 19-21, 2014 in conjunction with the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina
Andrew Olshan, PhD, professor and chair of the UNC Gillings School of Global Public Health’s Department of Epidemiology and UNC Lineberger associate director for population sciences, has been named the Barbara Sorenson Hulka Distinguished Professor of Cancer Epidemiology, effective March 1.
A non-invasive test that includes detection of the genetic abnormalities related to cancer could significantly improve the effectiveness of colon cancer screening, according to research published by a team of scientists including David Ransohoff, MD, professor of medicine at the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center member.
On March 5, Shelia Santacroce, PhD, UNC Lineberger Comprehensive Cancer Center Member and Beerstecher-Blackwell Distinguished Scholar, received a $50,000 research grant from Northwestern Mutual and the Alex’s Lemonade Stand Foundation (ALSF) to fund children’s cancer research.
Chad Ellis, PhD, has been appointed as associate director of UNC Lineberger Comprehensive Cancer Center, effective April 1, 2014.
Cancer patients who receive care from local physicians partnering with the medical research community are as likely to receive innovative treatments compared to patients treated at medical school affiliated hospitals, according to research from the University of North Carolina at Chapel Hill.